Sign In
Buy ACT
$40.57
-0.580 (-1.41%)
At Close: Jun 03, 2026
The "Geriatric Medicines Market - Growth, Trends, and Forecast (2020-2025)" report has been added to ResearchAndMarkets.com's offering.
Davidson Kempner Capital Management LP : Form 8.3 - Allergan PLC
02:20pm, Friday, 17'th Apr 2020
Ap19 FORM 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013 DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT.
Form 8.3 - Allergan plc
02:15pm, Friday, 17'th Apr 2020
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
1.
Outlook on the Worldwide Digestive Enzymes Industry to 2030 - Understand Customers Based on the Latest Market Research Findings
10:48am, Friday, 17'th Apr 2020
Dublin, April 17, 2020 -- The "Digestive Enzymes Market Global Report 2020-30" report has been added to ResearchAndMarkets.com's offering. The global digestive.
Global Geriatric Medicines Market Report 2020: Growth, Trends and Forecast to 2025 - ResearchAndMarkets.com
10:45am, Friday, 17'th Apr 2020
The "Geriatric Medicines Market - Growth, Trends, and Forecast (2020-2025)" report has been added to ResearchAndMarkets.com's offering.
Global Fibromyalgia Therapeutics Industry
04:22am, Friday, 17'th Apr 2020
New York, April 17, 2020 -- Reportlinker.com announces the release of the report "Global Fibromyalgia Therapeutics Industry" -.
10 of the Best Stocks to Buy for 2020
09:47pm, Thursday, 16'th Apr 2020
The 10 best stocks to buy for 2020. The 2010s were kind to the average Wall Street investor; the era ended as the first uninterrupted full-decade bull market in history. Going into 2020, the U.S. econ
AbbVie: Powerful R&D Portfolio Backing Strong Shareholder Returns
04:45pm, Thursday, 16'th Apr 2020
AbbVie has an impressive R&D portfolio that will back impressive shareholder returns. The company's Allergan acquisition is almost done. The company is focused
Davidson Kempner Capital Management LP : Form 8.3 - Allergan PLC
02:20pm, Thursday, 16'th Apr 2020
Ap19FORM 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013 DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT.
MILLENNIUM PARTNERS, L.P. UK Regulatory Announcement: Form 8.3 - Allergan plc
02:15pm, Thursday, 16'th Apr 2020
FORM 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013 DEALINGS BY PERSONS WITH INTERES
The "Oral Biologics & Biosimilars Market Global Report 2020-30" report has been added to ResearchAndMarkets.com's offering.
Form 8.3 -
01:36pm, Thursday, 16'th Apr 2020
FORM 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013 DEALINGS BY PERSONS WITH.
Global Oral Biologics & Biosimilars Market Global Report (2020 to 2030) - Identify Growth Segments for Investment
12:08pm, Thursday, 16'th Apr 2020
Dublin, April 16, 2020 -- The "Oral Biologics & Biosimilars Market Global Report 2020-30" report has been added to ResearchAndMarkets.com's offering. The.
Ellevest Inc. Has $32,000 Position in Allergan plc (NYSE:AGN)
09:36am, Thursday, 16'th Apr 2020
Ellevest Inc. grew its position in Allergan plc (NYSE:AGN) by 233.3% in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor own
UroGen Gets FDA Nod for Low-Grade Upper Tract Urothelial Cancer Drug
11:19pm, Wednesday, 15'th Apr 2020
The FDA on Wednesday approved a drug developed by UroGen Pharma to treat low-grade upper tract urothelial cancer, which rarely spreads but often recurs
